Department of Geriatrics, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.Obesity; Diabetes; Metabolism

This special issue will explore the interaction between obesity and human microbiota, with a focus on how gut microbiota affects metabolism by influencing microbial abundance, energy homeostasis, immune status, inflammation levels, fat accumulation, signaling pathways,etc, thereby partially alleviating obesity. The research scope of this type of problem includes basic or clinical studies related to gut microbiota, as well as applied research on the therapeutic potential of gut microbiota in metabolic and immune related diseases.
This project will provide new research directions:
- The impact of gut microbiota abundance on metabolism in obese individuals.
- The role of micro-organisms in regulating immune status.
- Intestinal microbiota regulates inflammation levels and affects body metabolism.
- The potential application of fecal microbiota transplantation in the treatment of metabolic system diseases.
- The therapeutic potential of gut probiotics in immune system diseases.
Management of obesity-related diseases through the gut microbiome
Obesity-associated gut dysbiosis: Metabolic dysfunction-associated steatotic liver disease as a clinical model of host–microbiome interactions
